risk of pancreatitis with tirzepatide GLP-1 Agonists and Risk: Reassessing an Old Concern New Evidence ⚠️ MOUNJARO (Tirzepatide) IS NOT

How Tirzepatide Affects Your Digestive System Tirzepatide activates GLP-1 and GIP receptors in your gut, slowing the rate at which food moves from your stomach into your small intestine

Mounjaro is generally not recommended for anyone with a personal or family history of certain thyroid cancers , which is why these checks are an important step in keeping your treatment safe

We will soon be expanding to all 50 US states

Understanding Retatrutide requires a breakdown of its tripartite action: 1

While highly effective for glycaemic control and weight reduction, Mounjaro has effects on gastrointestinal motility that require specific consideration in the perioperative setting

How Each Medication Works It works by mimicking a natural hormone in your body that stimulates insulin secretion from pancreatic beta cells when your blood sugar is high